Geode Capital Management
MD icon

Geode Capital Management’s Pediatrix Medical MD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$28.7M Sell
1,998,830
-15,298
-0.8% -$220K ﹤0.01% 1767
2025
Q1
$29.2M Buy
2,014,128
+66,332
+3% +$961K ﹤0.01% 1686
2024
Q4
$25.6M Buy
1,947,796
+11,045
+0.6% +$145K ﹤0.01% 1827
2024
Q3
$22.5M Buy
1,936,751
+45,155
+2% +$523K ﹤0.01% 1928
2024
Q2
$14.3M Buy
1,891,596
+74,840
+4% +$565K ﹤0.01% 2119
2024
Q1
$18.2M Buy
1,816,756
+37,348
+2% +$375K ﹤0.01% 1977
2023
Q4
$16.6M Buy
1,779,408
+80,404
+5% +$748K ﹤0.01% 2030
2023
Q3
$21.6M Buy
1,699,004
+67,644
+4% +$860K ﹤0.01% 1773
2023
Q2
$23.2M Buy
1,631,360
+83,125
+5% +$1.18M ﹤0.01% 1756
2023
Q1
$23.1M Buy
1,548,235
+61,284
+4% +$914K ﹤0.01% 1697
2022
Q4
$22.1M Buy
1,486,951
+17,285
+1% +$257K ﹤0.01% 1708
2022
Q3
$24.3M Sell
1,469,666
-11,349
-0.8% -$187K ﹤0.01% 1593
2022
Q2
$31.1M Buy
1,481,015
+106,474
+8% +$2.24M ﹤0.01% 1450
2022
Q1
$32.3M Buy
1,374,541
+31,086
+2% +$730K ﹤0.01% 1563
2021
Q4
$36.6M Buy
1,343,455
+1,187
+0.1% +$32.3K ﹤0.01% 1541
2021
Q3
$38.2M Buy
1,342,268
+712
+0.1% +$20.2K 0.01% 1497
2021
Q2
$40.4M Buy
1,341,556
+48,031
+4% +$1.45M 0.01% 1493
2021
Q1
$32.9M Buy
1,293,525
+99,003
+8% +$2.52M 0.01% 1536
2020
Q4
$29.3M Buy
1,194,522
+50,922
+4% +$1.25M ﹤0.01% 1474
2020
Q3
$18.6M Sell
1,143,600
-85,474
-7% -$1.39M ﹤0.01% 1589
2020
Q2
$21M Buy
1,229,074
+269,068
+28% +$4.6M ﹤0.01% 1474
2020
Q1
$11.2M Buy
960,006
+8,511
+0.9% +$99K ﹤0.01% 1670
2019
Q4
$26.4M Buy
951,495
+15,589
+2% +$433K 0.01% 1371
2019
Q3
$21.2M Buy
935,906
+5,188
+0.6% +$117K ﹤0.01% 1443
2019
Q2
$23.5M Sell
930,718
-65,081
-7% -$1.64M 0.01% 1375
2019
Q1
$27.1M Buy
995,799
+40,906
+4% +$1.11M 0.01% 1215
2018
Q4
$31.5M Buy
954,893
+26,586
+3% +$877K 0.01% 981
2018
Q3
$43.3M Buy
928,307
+26,256
+3% +$1.23M 0.01% 875
2018
Q2
$39M Buy
902,051
+64,358
+8% +$2.79M 0.01% 898
2018
Q1
$46.6M Buy
837,693
+51,384
+7% +$2.86M 0.02% 767
2017
Q4
$42M Sell
786,309
-2,051
-0.3% -$110K 0.01% 793
2017
Q3
$34M Buy
788,360
+37,270
+5% +$1.61M 0.01% 884
2017
Q2
$45.3M Buy
751,090
+49,973
+7% +$3.02M 0.02% 696
2017
Q1
$48.6M Buy
701,117
+67,314
+11% +$4.67M 0.02% 652
2016
Q4
$42.2M Buy
633,803
+22,204
+4% +$1.48M 0.02% 652
2016
Q3
$40.5M Buy
611,599
+22,004
+4% +$1.46M 0.02% 633
2016
Q2
$42.7M Buy
589,595
+17,191
+3% +$1.24M 0.02% 592
2016
Q1
$37K Buy
572,404
+22,537
+4% +$1.46K 0.02% 627
2015
Q4
$39.4M Buy
549,867
+5,104
+0.9% +$365K 0.02% 595
2015
Q3
$41.8M Buy
544,763
+6,319
+1% +$485K 0.03% 559
2015
Q2
$39.9M Buy
538,444
+14,668
+3% +$1.09M 0.02% 602
2015
Q1
$38M Buy
523,776
+10,011
+2% +$726K 0.02% 608
2014
Q4
$34M Buy
513,765
+13,135
+3% +$868K 0.02% 622
2014
Q3
$27.4M Buy
500,630
+2,438
+0.5% +$134K 0.02% 686
2014
Q2
$29M Buy
498,192
+8,254
+2% +$480K 0.02% 667
2014
Q1
$30.4M Buy
489,938
+25,365
+5% +$1.57M 0.02% 631
2013
Q4
$24.8M Buy
464,573
+250,269
+117% +$13.4M 0.02% 685
2013
Q3
$21.5M Buy
214,304
+18,024
+9% +$1.81M 0.02% 667
2013
Q2
$18M Buy
+196,280
New +$18M 0.02% 673